Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enanta Pharmaceutica (NQ: ENTA ) 11.32 +0.07 (+0.64%) Streaming Delayed Price Updated: 12:36 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enanta Pharmaceutica < Previous 1 2 3 4 5 6 7 Next > Enanta Pharmaceuticals Receives FDA Fast Track Designation for EDP-235, its Oral 3CL Protease Inhibitor Specifically Designed for the Treatment and Prevention of COVID-19 March 29, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals Announces Publication in The New England Journal of Medicine of Data from the Phase 2a Human Challenge Study of EDP-938 for the Treatment of Respiratory Syncytial Virus (RSV) February 17, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharma Commences Dosing In Phase 1 COVID-19 Trial February 16, 2022 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) has dosed the first subject in its Phase 1 trial of EDP-235, a coronavirus 3CL protease inhibitor, specifically designed as a... Via Benzinga Where Enanta Pharmaceuticals Stands With Analysts February 09, 2022 Enanta Pharmaceuticals (NASDAQ:ENTA) has observed the following analyst ratings within the last quarter: Via Benzinga Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-235, its Oral 3CL Protease Inhibitor Specifically Designed for the Treatment and Prevention of COVID-19 February 16, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire Can Anyone Challenge Pfizer's Covid Dominance? Why These Biotechs Say Yes February 11, 2022 Drug behemoth Pfizer was the first to launch a Covid antiviral pill — but a pack of small biotech stocks are already nipping at its heels. Via Investor's Business Daily Enanta Pharmaceuticals to Present at the SVB Leerink 11th Annual Global Healthcare Conference February 10, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals: Q1 Earnings Insights February 08, 2022 Enanta Pharmaceuticals (NASDAQ:ENTA) reported its Q1 earnings results on Tuesday, February 8, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Via Benzinga Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET February 08, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Host Conference Call on February 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2021 February 01, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire What 10 Analyst Ratings Have To Say About Enanta Pharmaceuticals January 13, 2022 Analysts have provided the following ratings for Enanta Pharmaceuticals (NASDAQ: Via Benzinga Earnings Scheduled For February 8, 2022 February 08, 2022 Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. Via Benzinga 10 Biggest Price Target Changes For Thursday January 13, 2022 RBC Capital boosted KB Home (NYSE: KBH) price target from $46 to $55. KB Home shares rose 6.7% to $45.20 in pre-market trading. Cowen & Co. reduced the price target on... Via Benzinga Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2022 at the 40th Annual J.P. Morgan Healthcare Conference January 06, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference January 04, 2022 From Enanta Pharmaceuticals, Inc. Via Business Wire 7 A-Rated Biotechs to Buy for the Long Run December 03, 2021 The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples. Via InvestorPlace Where Enanta Pharmaceuticals Stands With Analysts November 24, 2021 Over the past 3 months, 11 analysts have published their opinion on Enanta Pharmaceuticals (NASDAQ: Via Benzinga 56 Biggest Movers From Yesterday November 24, 2021 Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating... Via Benzinga Enanta Pharmaceuticals, inc (ENTA) Q4 2021 Earnings Call Transcript November 22, 2021 ENTA earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET November 22, 2021 From Enanta Pharmaceuticals, Inc. Via Business Wire 52 Biggest Movers From Friday November 22, 2021 Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second... Via Benzinga Earnings Scheduled For November 22, 2021 November 22, 2021 Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million. • Avaya... Via Benzinga The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week November 21, 2021 Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting... Via Talk Markets Exposures Product Safety The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week November 21, 2021 Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's Intraday Session November 19, 2021 Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... Via Benzinga Enanta Pharmaceuticals's Earnings: A Preview November 19, 2021 Enanta Pharmaceuticals (NASDAQ:ENTA) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement.... Via Benzinga The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial November 19, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack... Via Benzinga Safety Signals Force Enanta To Stop EDP-721 HBV Program November 19, 2021 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) has decided to discontinue the development of EDP-721, an oral Hepatitis B Virus (HBV) RNA destabilizer. The move follows... Via Benzinga Enanta Pharmaceuticals to Participate in December Investor Conferences November 19, 2021 From Enanta Pharmaceuticals, Inc. Via Business Wire Enanta Pharmaceuticals Announces Update to its Hepatitis B Virus (HBV) Program November 18, 2021 From Enanta Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
